Jump to content

Tony Kouzarides

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Rjwilmsi (talk | contribs) at 15:46, 27 January 2016 (→top: Journal cites, format journal names, using AWB (11837)). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Tony Kouzarides
Born (1958-01-17) 17 January 1958 (age 66)[36]
Alma materUniversity of Leeds (BSc)
University of Cambridge (PhD)
SpousePenny Hall[36]
AwardsHeinrich Wieland Prize (2013)
Fellow of the Royal Society (2012)[1]
FMedSci (2001)[2]
Scientific career
FieldsCancer
Chromatin
Transcription
InstitutionsUniversity of Leeds
University of Cambridge
Gurdon Institute
New York University
Laboratory of Molecular Biology
Abcam
ThesisA molecular analysis of transformation by human cytomegalovirus (1985)
Doctoral advisorTony Minson[3]
Doctoral studentsJacqui Sutherland[4]
Helen Brown[5]
Juliet Reid [6]
Klaus Martin[7][8]
Eric Miska[9]
Philip Zegerman[10][11]
Wendy Bergers
Dan Wolf[12]
Graeme Cuthbert[13]
Karen Halls
Claire Pike[14]
Other notable students(postdocs)
Christian Hagemeier[15]
Didier Trouche[16]
Jonathan Milner[17][18]
Alex Brehm[19]
Catherine Le Chalony
Søren Neilson
Paul Lavender[20]
Francois Fuks[21]
Marian Martinez Balbas
Laurence Vandel[22]
Uta-Maria Bauer[23]
Guida Ruas
Emma Langley[24]
Sylvain Daujat[25]
Luke Hughes-Davies[26]
Robert Schneider[27]
Steve Sanders[28]
Susana Lopes
Chris Nelson[29]
Paul Hurd[30]
Sopie Deltour
David Lando[31]
Antonis Kirmizis[32][33]
Hatice Akarsu
Blerta Xhemalce[34]
Till Bartke[35]
Marc Schneider
Gonçalo Castelo-Branco[14]
Websitewww.gurdon.cam.ac.uk/~kouzarideslab
royalsociety.org/people/tony-kouzarides

Tony Kouzarides, FMedSci,[2] FRS[1] (born 17 January 1958) is the deputy director of the Gurdon Institute,[37] a founding non-executive director of Abcam[38] and a Professor of Cancer Biology at the University of Cambridge.[39][40]

Education

Kouzarides was educated at the University of Leeds, graduating with a Bachelor of Science degree in Genetics in 1981.[36] He went on to complete his PhD at the University of Cambridge in 1985.[41]

Research

Following his PhD, Kouzarides did postdoctoral work at the Laboratory of Molecular Biology (LMB) on the cancer potential of cytomegalovirus.[42] and then on to New York University Medical Center. Here he examined the c-Fos leucine zipper dimerisation domain to elucidate its function. He got a job at the Gurdon Institute in Cambridge, where he has been since.[43]

Kouzarides is a leader in the field of chromatin modification[44] and its role in transcriptional control and cancer.[45][46] In 1996 he made a key discovery in finding that the transcriptional co-activator CBP[47] is a histone acetyltransferase.[48][49] He has since worked on identifying several new histone modifications, describing their functions in transcription and DNA repair and highlighting their mis-regulation in cancer. His demonstration that a histone acetylation pathway inhibitor can be used to treat MLL-leukaemias in has facilitated its use in clinical trials.[1]

Awards

Kouzarides was elected a member of the Academy of Medical Sciences (FMedSci) in 2001[2] a Fellow of the Royal Society (FRS) in 2012.[1] His nomination read:

"Tony Kouzarides is world leader in the field of chromatin modification and its roles in transcriptional control and cancer. His finding in 1996 that the transcriptional co-activator CBP is a histone acetyltransferase was one of the key discoveries that started the modern era of chromatin research. His subsequent work has identified several new histone modifications, described their functions in transcription and DNA repair and has highlighted their mis-regulation in cancer. His demonstration that a histone acetylation pathway inhibitor is an effective treatment for MLL-leukaemias in disease models has opened the way to its use in clinical trials."[1]

Kouzarides was also awarded the Sanofi-Cell Research Outstanding Paper Award of 2011[50] for his paper on Regulation of chromatin by histone modifications co-authored with Andrew Bannister.[51]

In 2013, he was awarded the Heinrich Wieland Prize for his pioneering "research on gene regulation and cancer"[52]

References

  1. ^ a b c d e "Professor Tony Kouzarides FMedSci FRS". Retrieved 24 April 2012.
  2. ^ a b c "The Academy of Medical Sciences | Directory of Fellows". Archived from the original on 2013-06-06.
  3. ^ Cranage, M. P.; Kouzarides, T.; Bankier, A. T.; Satchwell, S.; Weston, K.; Tomlinson, P.; Barrell, B.; Hart, H.; Bell, S. E.; Minson, A. C. (1986). "Identification of the human cytomegalovirus glycoprotein B gene and induction of neutralizing antibodies via its expression in recombinant vaccinia virus". The EMBO Journal. 5 (11): 3057–3063. PMC 1167261. PMID 3024973.
  4. ^ Sutherland, J. A.; Cook, A.; Bannister, A. J.; Kouzarides, T. (1992). "Conserved motifs in Fos and Jun define a new class of activation domain". Genes & Development. 6 (9): 1810–1819. doi:10.1101/gad.6.9.1810. PMID 1516835.
  5. ^ Brown, H. J.; Sutherland, J. A.; Cook, A.; Bannister, A. J.; Kouzarides, T. (1995). "An inhibitor domain in c-Fos regulates activation domains containing the HOB1 motif". The EMBO Journal. 14 (1): 124–131. PMC 398059. PMID 7828584.
  6. ^ Reid, J. L.; Bannister, A. J.; Zegerman, P.; Martínez-Balbás, M. A.; Kouzarides, T. (1998). "E1A directly binds and regulates the P/CAF acetyltransferase". The EMBO Journal. 17 (15): 4469–4477. doi:10.1093/emboj/17.15.4469. PMC 1170778. PMID 9687513.
  7. ^ Martin, K.; Trouche, D.; Hagemeier, C.; Sorensen, T. S.; La Thangue, N. B.; Kouzarides, T. (1995). "Stimulation of E2F1/DP1 transcriptional activity by MDM2 oncoprotein". Nature. 375 (6533): 691–694. doi:10.1038/375691a0. PMID 7791903. {{cite journal}}: horizontal tab character in |title= at position 58 (help)
  8. ^ Martin, K.; Trouche, D.; Hagemeier, C.; Kouzarides, T. (1995). "Regulation of transcription by E2F1/DP1". Journal of cell science. Supplement. 19: 91–94. doi:10.1242/jcs.1995.Supplement_19.13. PMID 8655653.
  9. ^ Miska, E. A.; Langley, E.; Wolf, D.; Karlsson, C.; Pines, J.; Kouzarides, T. (2001). "Differential localization of HDAC4 orchestrates muscle differentiation". Nucleic Acids Research. 29 (16): 3439–3447. doi:10.1093/nar/29.16.3439. PMC 55849. PMID 11504882.
  10. ^ Zegerman, P.; Canas, B.; Pappin, D.; Kouzarides, T. (2002). "Histone H3 Lysine 4 Methylation Disrupts Binding of Nucleosome Remodeling and Deacetylase (NuRD) Repressor Complex". Journal of Biological Chemistry. 277 (14): 11621–11624. doi:10.1074/jbc.C200045200. PMID 11850414.{{cite journal}}: CS1 maint: unflagged free DOI (link)
  11. ^ Zegerman, P.; Bannister, A. J.; Kouzarides, T. (2000). "The putative tumour suppressor Fus-2 is an N-acetyltransferase". Oncogene. 19 (1): 161–163. doi:10.1038/sj.onc.1203234. PMID 10644992.
  12. ^ Wolf, D.; Rodova, M.; Miska, E. A.; Calvet, J. P.; Kouzarides, T. (2002). "Acetylation of beta -Catenin by CREB-binding Protein (CBP)". Journal of Biological Chemistry. 277 (28): 25562–25567. doi:10.1074/jbc.M201196200. PMID 11973335.{{cite journal}}: CS1 maint: unflagged free DOI (link)
  13. ^ Cuthbert, G. L.; Daujat, S.; Snowden, A. W.; Erdjument-Bromage, H.; Hagiwara, T.; Yamada, M.; Schneider, R.; Gregory, P. D.; Tempst, P.; Bannister, A. J.; Kouzarides, T. (2004). "Histone Deimination Antagonizes Arginine Methylation". Cell. 118 (5): 545–553. doi:10.1016/j.cell.2004.08.020. PMID 15339660.
  14. ^ a b "Tony Kouzarides lab Alumni". Archived from the original on 2013-06-06.
  15. ^ Hagemeier, C.; Bannister, A. J.; Cook, A.; Kouzarides, T. (1993). "The activation domain of transcription factor PU.1 binds the retinoblastoma (RB) protein and the transcription factor TFIID in vitro: RB shows sequence similarity to TFIID and TFIIB". Proceedings of the National Academy of Sciences of the United States of America. 90 (4): 1580–1584. doi:10.1073/pnas.90.4.1580. PMC 45918. PMID 8434021.
  16. ^ Trouche, D.; Kouzarides, T. (1996). "E2F1 and E1A(12S) have a homologous activation domain regulated by RB and CBP". Proceedings of the National Academy of Sciences of the United States of America. 93 (4): 1439–1442. doi:10.1073/pnas.93.4.1439. PMC 39957. PMID 8643650.
  17. ^ Milner, J.; Fuks, F. O.; Hughes-Davies, L.; Kouzarides, T. (2000). "The BRCA2 activation domain associates with and is phosphorylated by a cellular protein kinase". Oncogene. 19 (38): 4441–4445. doi:10.1038/sj.onc.1203793. PMID 10980621.
  18. ^ Milner, J.; Ponder, B.; Hughes-Davies, L.; Seltmann, M.; Kouzarides, T. (1997). "Transcriptional activation functions in BRCA2". Nature. 386 (6627): 772–773. doi:10.1038/386772a0. PMID 9126734.
  19. ^ Kouzarides, T.; Brehm, A.; Miska, E. A.; McCance, D. J.; Reid, J. L.; Bannister, A. J. (1998). "Retinoblastoma protein recruits histone deacetylase to repress transcription". Nature. 391 (6667): 597–601. doi:10.1038/35404. PMID 9468139.
  20. ^ Lavender, P.; Vandel, L.; Bannister, A. J.; Kouzarides, T. (1997). "The HMG-box transcription factor HBP1 is targeted by the pocket proteins and E1A". Oncogene. 14 (22): 2721–2728. doi:10.1038/sj.onc.1201243. PMID 9178770.
  21. ^ Fuks, F.; Hurd, P. J.; Deplus, R.; Kouzarides, T. (2003). "The DNA methyltransferases associate with HP1 and the SUV39H1 histone methyltransferase". Nucleic Acids Research. 31 (9): 2305–2312. doi:10.1093/nar/gkg332. PMC 154218. PMID 12711675.
  22. ^ Vandel, L.; Kouzarides, T. (1999). "Residues phosphorylated by TFIIH are required for E2F-1 degradation during S-phase". The EMBO Journal. 18 (15): 4280–4291. doi:10.1093/emboj/18.15.4280. PMC 1171504. PMID 10428966.
  23. ^ Bauer, U. -M.; Daujat, S.; Nielsen, S. J.; Nightingale, K.; Kouzarides, T. (2001). "Methylation at arginine 17 of histone H3 is linked to gene activation". EMBO Reports. 3 (1): 39–44. doi:10.1093/embo-reports/kvf013. PMC 1083932. PMID 11751582.
  24. ^ Langley, E.; Pearson, M.; Faretta, M.; Bauer, U. M.; Frye, R. A.; Minucci, S.; Pelicci, P. G.; Kouzarides, T. (2002). "Human SIR2 deacetylates p53 and antagonizes PML/p53-induced cellular senescence". The EMBO Journal. 21 (10): 2383–2396. doi:10.1093/emboj/21.10.2383. PMC 126010. PMID 12006491.
  25. ^ Daujat, S.; Bauer, U. M.; Shah, V.; Turner, B.; Berger, S.; Kouzarides, T. (2002). "Crosstalk between CARM1 methylation and CBP acetylation on histone H3". Current biology : CB. 12 (24): 2090–2097. doi:10.1016/s0960-9822(02)01387-8. PMID 12498683.
  26. ^ Hughes-Davies, L.; Huntsman, D.; Ruas, M.; Fuks, F.; Bye, J.; Chin, S. F.; Milner, J.; Brown, L. A.; Hsu, F.; Gilks, B.; Nielsen, T.; Schulzer, M.; Chia, S.; Ragaz, J.; Cahn, A.; Linger, L.; Ozdag, H.; Cattaneo, E.; Jordanova, E. S.; Schuuring, E.; Yu, D. S.; Venkitaraman, A.; Ponder, B.; Doherty, A.; Aparicio, S.; Bentley, D.; Theillet, C.; Ponting, C. P.; Caldas, C.; Kouzarides, T. (2003). "EMSY links the BRCA2 pathway to sporadic breast and ovarian cancer". Cell. 115 (5): 523–535. doi:10.1016/S0092-8674(03)00930-9. PMID 14651845.
  27. ^ Schneider, R.; Bannister, A. J.; Weise, C.; Kouzarides, T. (2004). "Direct Binding of INHAT to H3 Tails Disrupted by Modifications". Journal of Biological Chemistry. 279 (23): 23859–23862. doi:10.1074/jbc.C400151200. PMID 15100215.{{cite journal}}: CS1 maint: unflagged free DOI (link)
  28. ^ Sanders, S. L.; Portoso, M.; Mata, J.; Bähler, J. R.; Allshire, R. C.; Kouzarides, T. (2004). "Methylation of Histone H4 Lysine 20 Controls Recruitment of Crb2 to Sites of DNA Damage". Cell. 119 (5): 603–614. doi:10.1016/j.cell.2004.11.009. PMID 15550243.
  29. ^ Nelson, C. J.; Santos-Rosa, H.; Kouzarides, T. (2006). "Proline Isomerization of Histone H3 Regulates Lysine Methylation and Gene Expression". Cell. 126 (5): 905–916. doi:10.1016/j.cell.2006.07.026. PMID 16959570.
  30. ^ Hurd, P. J.; Bannister, A. J.; Halls, K.; Dawson, M. A.; Vermeulen, M.; Olsen, J. V.; Ismail, H.; Somers, J.; Mann, M.; Owen-Hughes, T.; Gout, I.; Kouzarides, T. (2009). "Phosphorylation of Histone H3 Thr-45 is Linked to Apoptosis". Journal of Biological Chemistry. 284 (24): 16575–16583. doi:10.1074/jbc.M109.005421. PMC 2713519. PMID 19363025.{{cite journal}}: CS1 maint: unflagged free DOI (link)
  31. ^ Lando, D.; Balmer, J.; Laue, E. D.; Kouzarides, T. (2012). Kashanchi, Fatah (ed.). "The S. Pombe Histone H2A Dioxygenase Ofd2 Regulates Gene Expression during Hypoxia". PLoS ONE. 7 (1): e29765. doi:10.1371/journal.pone.0029765. PMC 3250473. PMID 22235339.{{cite journal}}: CS1 maint: unflagged free DOI (link)
  32. ^ Kirmizis, A.; Santos-Rosa, H.; Penkett, C. J.; Singer, M. A.; Green, R. D.; Kouzarides, T. (2009). "Distinct transcriptional outputs associated with mono- and dimethylated histone H3 arginine 2". Nature Structural & Molecular Biology. 16 (4): 449–451. doi:10.1038/nsmb.1569. PMC 3350867. PMID 19270702.
  33. ^ Kirmizis, A.; Santos-Rosa, H.; Penkett, C. J.; Singer, M. A.; Vermeulen, M.; Mann, M.; Bähler, J. R.; Green, R. D.; Kouzarides, T. (2007). "Arginine methylation at histone H3R2 controls deposition of H3K4 trimethylation". Nature. 449 (7164): 928–932. doi:10.1038/nature06160. PMC 3350864. PMID 17898715.
  34. ^ Xhemalce, B.; Robson, S. C.; Kouzarides, T. (2012). "Human RNA Methyltransferase BCDIN3D Regulates MicroRNA Processing". Cell. 151 (2): 278–288. doi:10.1016/j.cell.2012.08.041. PMC 3640255. PMID 23063121.
  35. ^ Bartke, T.; Vermeulen, M.; Xhemalce, B.; Robson, S. C.; Mann, M.; Kouzarides, T. (2010). "Nucleosome-Interacting Proteins Regulated by DNA and Histone Methylation". Cell. 143 (3): 470–484. doi:10.1016/j.cell.2010.10.012. PMC 3640253. PMID 21029866.
  36. ^ a b c "KOUZARIDES, Prof. Tony". Who's Who 2013, A & C Black, an imprint of Bloomsbury Publishing plc, 2013; online edn, Oxford University Press. Retrieved 18 March 2015. (subscription required)
  37. ^ "The Kouzarides Lab at the Gurdon Institute". Retrieved 24 April 2012.
  38. ^ "Abcam board of directors". Retrieved 24 April 2012.
  39. ^ "Professor Tony Kouzarides profile- Cambridge Cancer Centre". Archived from the original on 6 June 2013.
  40. ^ Bannister, A. J.; Zegerman, P.; Partridge, J. F.; Miska, E. A.; Thomas, J. O.; Allshire, R. C.; Kouzarides, T. (2001). "Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain". Nature. 410 (6824): 120–124. doi:10.1038/35065138. PMID 11242054.
  41. ^ Kouzarides, Tony (1985). A molecular analysis of transformation by human cytomegalovirus (PhD thesis). University of Cambridge.
  42. ^ Laursen, L. (2008). "Creativity and Persistence Overcome Failure: Tony Kouzarides tells the story of his early career as a comedy of errors". Science. doi:10.1126/science.caredit.a0800097.
  43. ^ "About Tony Kouzarides". Retrieved 24 April 2012.
  44. ^ Kouzarides, T. (2007). "Chromatin Modifications and Their Function". Cell. 128 (4): 693–705. doi:10.1016/j.cell.2007.02.005. PMID 17320507.
  45. ^ "Tony Kouzarides publications in Google Scholar". Retrieved 24 April 2012.
  46. ^ http://www.ncbi.nlm.nih.gov/pubmed?term=kouzarides Kouzarides in PubMed
  47. ^ Bannister, A. J.; Kouzarides, T. (1996). "The CBP co-activator is a histone acetyltransferase". Nature. 384 (6610): 641–643. doi:10.1038/384641a0. PMID 8967953.
  48. ^ Kouzarides, T.; Brehm, A.; Miska, E. A.; McCance, D. J.; Reid, J. L.; Bannister, A. J. (1998). "Retinoblastoma protein recruits histone deacetylase to repress transcription". Nature. 391 (6667): 597–601. doi:10.1038/35404. PMID 9468139.
  49. ^ Santos-Rosa, H.; Schneider, R.; Bannister, A. J.; Sherriff, J.; Bernstein, B. E.; Emre, N. C. T.; Schreiber, S. L.; Mellor, J.; Kouzarides, T. (2002). "Active genes are tri-methylated at K4 of histone H3". Nature. 419 (6905): 407–411. doi:10.1038/nature01080. PMID 12353038.
  50. ^ Li, D. (2012). "Sanofi-Cell Research Outstanding Paper Award of 2011". Cell Research. 22 (11): 1511. doi:10.1038/cr.2012.153. PMC 3494390. PMID 23128785.
  51. ^ Bannister, A. J.; Kouzarides, Tony (2011). "Regulation of chromatin by histone modifications". Cell Research. 21 (3): 381–395. doi:10.1038/cr.2011.22. PMC 3193420. PMID 21321607.
  52. ^ Heinrich Wieland Prize; accessed 18 March 2015. Template:De icon

Template:Persondata

Retrieved from "https://en.wikipedia.org/w/index.php?title=Tony_Kouzarides&oldid=701955893"